In addition, cells expressing EWS-FLI were approximately 10-fold more sensitive to HCI-2509 treatment compared to cells with shRNA-mediated depletion of EWS-FLI, underscoring the specificity of LSD1 inhibition for Ewing sarcoma cells. This evidence concerns the gene FLII and Ewing sarcoma.